An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
Clinical trial NCT03924427 · COMPLETED
Trial details
- NCT number
- NCT03924427
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-10
- Primary completion
- 2021-03-24
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.